| Income Statement |
| Operating Expenses | 6.27M |
|
| Research and Development Expense | 5.21M |
| Selling, General and Administrative Expense | 1.07M |
| Operating Income | -6.27M |
| Income Tax Expense | 49.00K |
| Net Income | -5.50M |
| Net Income Common Stock | -5.50M |
| Net Income Common Stock (USD) | -5.50M |
| Consolidated Income | -5.50M |
| Earnings per Basic Share | -0.18 |
| Earnings per Basic Share (USD) | -0.18 |
| Earnings per Diluted Share | -0.18 |
| Earning Before Interest & Taxes (EBIT) | -5.46M |
| Earning Before Interest & Taxes (USD) | -5.46M |
| Weighted Average Shares | 30.49M |
| Weighted Average Shares Diluted | 30.49M |
| Balance Sheet |
| Cash and Equivalents | 115.46M |
| Cash and Equivalents (USD) | 115.46M |
| Current Assets | 117.05M |
| Property, Plant & Equipment Net | 22.79M |
| Total Assets | 139.84M |
| Current Liabilities | 3.00M |
| Total Liabilities | 4.82M |
| Accumulated Retained Earnings (Deficit) | -141.88M |
| Shareholders Equity | 135.02M |
| Shareholders Equity (USD) | 135.02M |
| Assets Non-Current | 22.79M |
| Liabilities Non-Current | 1.82M |
| Trade and Non-Trade Payables | 857.00K |
| Tax Liabilities | 1.93M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 332.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -10.09M |
| Capital Expenditure | 9.00K |
| Net Cash Flow from Investing | 9.00K |
| Net Cash Flow from Operations | -8.97M |
| Effect of Exchange Rate Changes on Cash | -1.13M |
| Share Based Compensation | 172.00K |